Mild fatigue on injection day that resolves within 24 hours represents normal response
You may be a candidate if: You have documented excess visceral fat with imaging or waist circumference criteria You have features of metabolic syndrome elevated triglycerides, insulin resistance, impaired fasting glucose You have evidence of GH-axis insufficiency or age-related GH decline (low IGF-1) You have not achieved adequate visceral fat reduction through lifestyle modification alone You are being treated for HIV-associated lipodystrophy (the FDA-approved indication) You are not pregnant and do not have active malignancy both are absolute contraindications Lab workup typically includes: Fasting IGF-1 level Fasting glucose and insulin (HOMA-IR for insulin resistance) Full lipid panel Hemoglobin A1c Liver function tests Baseline CT or MRI for VAT quantification (in research settings) Meto's Comprehensive Metabolic Panel covers the core biomarkers fasting glucose, fasting insulin, lipid panel, liver markers, and inflammation markers giving your provider the baseline data needed to evaluate your candidacy accurately
If these are negative and the patient spontaneously improves, no further workup may occur
Wearing your retainer as directed is key to keeping your teeth aligned and protecting the investment youve made in your smile
To gain insight into the molecular mechanism of action of GLP-1 peptides, here we report the crystal structure of the full-length GLP-1 receptor bound to a truncated peptide agonist
No single approach suits everyone, and combination strategies often yield the best outcomes
